Clinical Research

Hoping to Improve Resection Outcomes
Risk-based, protocol-driven post-operative management approaches did not improve surgical outcomes in cancer resection patients.
Read now

Study Challenges Standard Surgery Protocols for Patients with High A1C
A new retrospective study suggests that an elevated A1C shouldn’t prevent patients from getting revisional bariatric surgery because it can help treat high blood glucose while having no associated negative effect on postoperative complications.
Read now

Keeping An Eye on The Sky
Researcher achieves dream of working with NASA to improve astronauts’ eye health.
Read now

Connecting The Link
Houston Methodist researchers have discovered a bidirectional link between chronic sinusitis, anxiety and depression.
Read now

Transforming Healthcare Through Reducing Amputations
Houston Methodist researchers provide insights on deep venous arterialization that may play a pivotal role in reducing amputations in chronic limb threatening ischaemia patients.
Read now

Trailblazing New Perspectives: Treating Gynecological Cancers
The goal of this new study was to evaluate the feasibility of a phase three, multi-center randomized clinical trial comparing the efficacy of minimally invasive surgery with that of the traditional open method approach (laparotomy) in treating epithelial ovarian cancer.
Read now

Evolving Treatment Beyond Pharmaceuticals
First-of-its-Kind Study Explores Novel Prescription Digital Therapeutic
Read now

An Unusual Presentation of Glioblastoma
Andrew Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, recently published one of the first-ever reported cases of progressive vision loss as the presenting manifestation of recurrent GBM with secondary LMS to the optic chiasm.
Read now

Putting IUS Into Practice
Houston Methodist physician scientists offer practical steps for incorporating IUS into IBD practice including training requirements, equipment, and protocols.
Read now

Cancer cell type (seed) and tumor microenvironment (soil) control therapeutic antibody delivery and efficacy
Primary tumor cells (seed) and metastatic organs (soil) determine complex tumor microenvironment heterogeneities- a major cause of resistance against immunotherapeutics, including immune checkpoint inhibitors important in breast cancer treatment strategies.
Read now
Share this story